Transient increase of serum granulysin in a stage IVs neuroblastoma patient during spontaneous regression: Case report [1]

International Journal of Hematology

Volumn 82, Issue 5, 2005, Pages 456-457

  Nagasawa, Masayuki ^a   Kawamoto, Hiroshi ^a   Tsuji, Yoichirou ^a   Mizutani, Shuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 125; CYCLOPHOSPHAMIDE; GRANULYSIN; ISOTRETINOIN; GNLY PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN;

ADJUVANT THERAPY; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INFANT; LABORATORY TEST; LETTER; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; ABDOMINAL TUMOR; BLOOD; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RADIOGRAPHY; TUMOR REGRESSION;

ABDOMINAL NEOPLASMS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; COMBINED MODALITY THERAPY; HUMANS; INFANT; MALE; NEOPLASM REGRESSION, SPONTANEOUS; NEUROBLASTOMA;

EID: 33646444614     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05091     Document Type: Letter

References (11)

1. Pritchard J, Hickman JA. Why does stage 4s neuroblastoma regress spontaneously? Lancet. 1994;344:869-870.
2. Kitanaka C, Kato K, Ijiri R, et al. Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression. J Natl Cancer Inst. 2002;94:358-368.
3. Gestblom C, Hoehner JC, Pahlman S. Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index. Eur J Cancer. 1995;31:458-463.
4. Kishi A, Takamori Y, Ogawa K, et al. Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer. Cancer Immunol Immunother. 2002;50:604-614.
5. Ogawa K, Takamori Y, Nagasawa M, et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur J Immunol. 2003;33:1925-1933.
6. Ochoa MT, Stenger S, Sieling PA, et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med. 2001;7:174-179.
7. Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 1998;282: 121-125.
8. Dieli F, Troye-Blomberg M, Ivanyi J, et al. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T lymphocytes. J Infect Dis. 2001;184:1082-1085.
9. Gamen S, Hanson DA, Kaspar A, Naval J, Krensky AM, Anel A. Granulysin-induced apoptosis, I: involvement of at least two distinct pathways. J Immunol. 1998;161:1758-1764.
10. Matthay KK, Perez C, Seeger RC, et al. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol. 1998;16:1256-1264.
11. Chicheportiche Y, Bourdon PR, Xu H, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem. 1997;272:32401-32410.